ID   SUV39_DROME             Reviewed;         635 AA.
AC   P45975; Q9VFA6;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   21-NOV-2003, sequence version 2.
DT   07-APR-2021, entry version 200.
DE   RecName: Full=Histone-lysine N-methyltransferase Su(var)3-9;
DE            EC=2.1.1.355 {ECO:0000269|PubMed:11867540};
DE   AltName: Full=Histone H3-K9 methyltransferase;
DE            Short=H3-K9-HMTase;
DE   AltName: Full=Lysine N-methyltransferase 1;
DE   AltName: Full=Protein suppressor of variegation 3-9;
GN   Name=Su(var)3-9; Synonyms=KMT1; ORFNames=CG6476;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC   Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha; Ephydroidea;
OC   Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND DEVELOPMENTAL STAGE.
RC   STRAIN=Oregon-R;
RX   PubMed=7915232; DOI=10.1002/j.1460-2075.1994.tb06693.x;
RA   Tschiersch B., Hofmann A., Krauss V., Dorn R., Korge G., Reuter G.;
RT   "The protein encoded by the Drosophila position-effect variegation
RT   suppressor gene Su(var)3-9 combines domains of antagonistic regulators of
RT   homeotic gene complexes.";
RL   EMBO J. 13:3822-3831(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Karsnas;
RX   PubMed=11063691;
RA   Krauss V., Reuter G.;
RT   "Two genes become one: the genes encoding heterochromatin protein Su(var)3-
RT   9 and translation initiation factor subunit eIF-2gamma are joined to a
RT   dicistronic unit in holometabolic insects.";
RL   Genetics 156:1157-1167(2000).
RN   [3]
RP   SEQUENCE REVISION TO 509.
RA   Schotta G., Ebert A., Lein S., Kubicek S., Krauss V., Jenuwein T.,
RA   Reuter F.;
RT   "Histone H3-K9 methylation potential of Drosophila Su(var)3-9 mutants
RT   correlates with extent of gene silencing.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X., Brandon R.C.,
RA   Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D., Wan K.H., Doyle C.,
RA   Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G., Abril J.F., Agbayani A.,
RA   An H.-J., Andrews-Pfannkoch C., Baldwin D., Ballew R.M., Basu A.,
RA   Baxendale J., Bayraktaroglu L., Beasley E.M., Beeson K.Y., Benos P.V.,
RA   Berman B.P., Bhandari D., Bolshakov S., Borkova D., Botchan M.R., Bouck J.,
RA   Brokstein P., Brottier P., Burtis K.C., Busam D.A., Butler H., Cadieu E.,
RA   Center A., Chandra I., Cherry J.M., Cawley S., Dahlke C., Davenport L.B.,
RA   Davies P., de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I.,
RA   Dietz S.M., Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C.,
RA   Dunn P., Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S.,
RA   Fleischmann W., Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M.,
RA   Glasser K., Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J., Hostin D.,
RA   Houston K.A., Howland T.J., Wei M.-H., Ibegwam C., Jalali M., Kalush F.,
RA   Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A., Kimmel B.E., Kodira C.D.,
RA   Kraft C.L., Kravitz S., Kulp D., Lai Z., Lasko P., Lei Y., Levitsky A.A.,
RA   Li J.H., Li Z., Liang Y., Lin X., Liu X., Mattei B., McIntosh T.C.,
RA   McLeod M.P., McPherson D., Merkulov G., Milshina N.V., Mobarry C.,
RA   Morris J., Moshrefi A., Mount S.M., Moy M., Murphy B., Murphy L.,
RA   Muzny D.M., Nelson D.L., Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R.,
RA   Pacleb J.M., Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V.,
RA   Reese M.G., Reinert K., Remington K., Saunders R.D.C., Scheeler F.,
RA   Shen H., Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E., Svirskas R.,
RA   Tector C., Turner R., Venter E., Wang A.H., Wang X., Wang Z.-Y.,
RA   Wassarman D.A., Weinstock G.M., Weissenbach J., Williams S.M., Woodage T.,
RA   Worley K.C., Wu D., Yang S., Yao Q.A., Ye J., Yeh R.-F., Zaveri J.S.,
RA   Zhan M., Zhang G., Zhao Q., Zheng L., Zheng X.H., Zhong F.N., Zhong W.,
RA   Zhou X., Zhu S.C., Zhu X., Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M.,
RA   Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [5]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q., Stapleton M.,
RA   Yamada C., Ashburner M., Gelbart W.M., Rubin G.M., Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a systematic
RT   review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [6]
RP   INTERACTION WITH RPD3.
RX   PubMed=11571273; DOI=10.1093/embo-reports/kve210;
RA   Czermin B., Schotta G., Huelsmann B.B., Brehm A., Becker P.B., Reuter G.,
RA   Imhof A.;
RT   "Physical and functional association of SU(VAR)3-9 and HDAC1 in
RT   Drosophila.";
RL   EMBO Rep. 2:915-919(2001).
RN   [7]
RP   CATALYTIC ACTIVITY, AND INTERACTION WITH SU(VAR)205 AND SU(VAR)3-7.
RX   PubMed=11867540; DOI=10.1093/emboj/21.5.1121;
RA   Schotta G., Ebert A., Krauss V., Fischer A., Hoffmann J., Rea S.,
RA   Jenuwein T., Dorn R., Reuter G.;
RT   "Central role of Drosophila SU(VAR)3-9 in histone H3-K9 methylation and
RT   heterochromatic gene silencing.";
RL   EMBO J. 21:1121-1131(2002).
RN   [8]
RP   FUNCTION.
RX   PubMed=14630943; DOI=10.1101/gad.281503;
RA   Greil F., van der Kraan I., Delrow J., Smothers J.F., de Wit E.,
RA   Bussemaker H.J., van Driel R., Henikoff S., van Steensel B.;
RT   "Distinct HP1 and Su(var)3-9 complexes bind to sets of developmentally
RT   coexpressed genes depending on chromosomal location.";
RL   Genes Dev. 17:2825-2838(2003).
CC   -!- FUNCTION: Histone methyltransferase that specifically trimethylates
CC       'Lys-9' of histone H3 using monomethylated H3 'Lys-9' as substrate. H3
CC       'Lys-9' trimethylation represents a specific tag for epigenetic
CC       transcriptional repression by recruiting Su(var)205/HP1 to methylated
CC       histones. Mainly functions in heterochromatin regions, thereby playing
CC       a central role in the establishment of constitutive heterochromatin at
CC       pericentric regions. Involved in heterochromatic gene silencing
CC       including the modification of position-effect-variegation.
CC       {ECO:0000269|PubMed:14630943}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-lysyl(9)-[histone H3] + 3 S-adenosyl-L-methionine = 3 H(+) +
CC         N(6),N(6),N(6)-trimethyl-L-lysyl(9)-[histone H3] + 3 S-adenosyl-L-
CC         homocysteine; Xref=Rhea:RHEA:60276, Rhea:RHEA-COMP:15538, Rhea:RHEA-
CC         COMP:15546, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:57856,
CC         ChEBI:CHEBI:59789, ChEBI:CHEBI:61961; EC=2.1.1.355;
CC         Evidence={ECO:0000269|PubMed:11867540};
CC   -!- SUBUNIT: Interacts with Su(var)205 and Su(var)3-7. Probably associates
CC       with Rpd3. {ECO:0000269|PubMed:11571273, ECO:0000269|PubMed:11867540}.
CC   -!- INTERACTION:
CC       P45975; P02255: His1:CG33843; NbExp=4; IntAct=EBI-110378, EBI-151629;
CC       P45975; P05205: Su(var)205; NbExp=3; IntAct=EBI-110378, EBI-155532;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome, centromere. Note=Associates
CC       with centromeric constitutive heterochromatin.
CC   -!- DEVELOPMENTAL STAGE: Expressed maternally and zygotically. Expressed
CC       throughout development with a peak of expression during early
CC       embryogenesis (0-9 hours old embryos). Weak expression in larvae, pupae
CC       and adult flies. {ECO:0000269|PubMed:7915232}.
CC   -!- DOMAIN: Although the SET domain contains the active site of enzymatic
CC       activity, both pre-SET and post-SET domains are required for
CC       methyltransferase activity. The SET domain also participates in stable
CC       binding to heterochromatin (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: In the pre-SET domain, Cys residues bind 3 zinc ions that are
CC       arranged in a triangular cluster; some of these Cys residues contribute
CC       to the binding of two zinc ions within the cluster. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the class V-like SAM-binding methyltransferase
CC       superfamily. Histone-lysine methyltransferase family. Suvar3-9
CC       subfamily. {ECO:0000255|PROSITE-ProRule:PRU00190}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X80070; CAA56376.1; -; mRNA.
DR   EMBL; AJ290956; CAB93768.2; -; Genomic_DNA.
DR   EMBL; AE014297; AAF55154.1; -; Genomic_DNA.
DR   PIR; S47004; S47004.
DR   RefSeq; NP_524357.2; NM_079633.3.
DR   SMR; P45975; -.
DR   BioGRID; 66596; 41.
DR   DIP; DIP-23970N; -.
DR   IntAct; P45975; 3.
DR   MINT; P45975; -.
DR   STRING; 7227.FBpp0302536; -.
DR   BindingDB; P45975; -.
DR   ChEMBL; CHEMBL2169720; -.
DR   PaxDb; P45975; -.
DR   PRIDE; P45975; -.
DR   GeneID; 41483; -.
DR   KEGG; dme:Dmel_CG43664; -.
DR   CTD; 41483; -.
DR   FlyBase; FBgn0263755; Su(var)3-9.
DR   eggNOG; KOG1082; Eukaryota.
DR   HOGENOM; CLU_020840_8_1_1; -.
DR   InParanoid; P45975; -.
DR   PhylomeDB; P45975; -.
DR   Reactome; R-DME-427359; SIRT1 negatively regulates rRNA expression.
DR   SABIO-RK; P45975; -.
DR   BioGRID-ORCS; 41483; 1 hit in 3 CRISPR screens.
DR   GenomeRNAi; 41483; -.
DR   PRO; PR:P45975; -.
DR   Proteomes; UP000000803; Chromosome 3R.
DR   Bgee; FBgn0263755; Expressed in embryo and 32 other tissues.
DR   ExpressionAtlas; P45975; baseline and differential.
DR   Genevisible; P45975; DM.
DR   GO; GO:0000775; C:chromosome, centromeric region; TAS:FlyBase.
DR   GO; GO:0000781; C:chromosome, telomeric region; IEA:GOC.
DR   GO; GO:0000792; C:heterochromatin; IDA:FlyBase.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005701; C:polytene chromosome chromocenter; IDA:FlyBase.
DR   GO; GO:0003682; F:chromatin binding; IDA:FlyBase.
DR   GO; GO:0042054; F:histone methyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0046974; F:histone methyltransferase activity (H3-K9 specific); IDA:FlyBase.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006325; P:chromatin organization; IMP:FlyBase.
DR   GO; GO:0006342; P:chromatin silencing; HMP:FlyBase.
DR   GO; GO:0006348; P:chromatin silencing at telomere; HMP:FlyBase.
DR   GO; GO:0051276; P:chromosome organization; IMP:FlyBase.
DR   GO; GO:0006306; P:DNA methylation; IMP:FlyBase.
DR   GO; GO:0048132; P:female germ-line stem cell asymmetric division; IDA:FlyBase.
DR   GO; GO:0016458; P:gene silencing; IMP:FlyBase.
DR   GO; GO:0031507; P:heterochromatin assembly; IMP:FlyBase.
DR   GO; GO:0070828; P:heterochromatin organization; IMP:FlyBase.
DR   GO; GO:0070868; P:heterochromatin organization involved in chromatin silencing; IMP:FlyBase.
DR   GO; GO:0051567; P:histone H3-K9 methylation; IDA:FlyBase.
DR   GO; GO:0034968; P:histone lysine methylation; IBA:GO_Central.
DR   GO; GO:0016571; P:histone methylation; IDA:FlyBase.
DR   GO; GO:0016570; P:histone modification; IMP:FlyBase.
DR   GO; GO:2001229; P:negative regulation of response to gamma radiation; IMP:FlyBase.
DR   GO; GO:0048477; P:oogenesis; IDA:FlyBase.
DR   GO; GO:0031508; P:pericentric heterochromatin assembly; HMP:FlyBase.
DR   InterPro; IPR016197; Chromo-like_dom_sf.
DR   InterPro; IPR000953; Chromo/chromo_shadow_dom.
DR   InterPro; IPR023780; Chromo_domain.
DR   InterPro; IPR023779; Chromodomain_CS.
DR   InterPro; IPR011381; Histone_H3-K9_MeTrfase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR003616; Post-SET_dom.
DR   InterPro; IPR007728; Pre-SET_dom.
DR   InterPro; IPR001214; SET_dom.
DR   Pfam; PF00385; Chromo; 1.
DR   Pfam; PF05033; Pre-SET; 1.
DR   Pfam; PF00856; SET; 1.
DR   PIRSF; PIRSF009343; SUV39_SET; 1.
DR   SMART; SM00298; CHROMO; 1.
DR   SMART; SM00468; PreSET; 1.
DR   SMART; SM00317; SET; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF54160; SSF54160; 1.
DR   PROSITE; PS00598; CHROMO_1; 1.
DR   PROSITE; PS50013; CHROMO_2; 1.
DR   PROSITE; PS50868; POST_SET; 1.
DR   PROSITE; PS50867; PRE_SET; 1.
DR   PROSITE; PS50280; SET; 1.
PE   1: Evidence at protein level;
KW   Centromere; Chromatin regulator; Chromosome; Metal-binding;
KW   Methyltransferase; Nucleus; Reference proteome; Repressor;
KW   S-adenosyl-L-methionine; Transcription; Transcription regulation;
KW   Transferase; Zinc.
FT   CHAIN           1..635
FT                   /note="Histone-lysine N-methyltransferase Su(var)3-9"
FT                   /id="PRO_0000186061"
FT   DOMAIN          219..278
FT                   /note="Chromo"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00053"
FT   DOMAIN          410..474
FT                   /note="Pre-SET"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00157"
FT   DOMAIN          477..603
FT                   /note="SET"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00190"
FT   DOMAIN          619..635
FT                   /note="Post-SET"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00155"
FT   REGION          81..188
FT                   /note="Binds to Su(var)205 and Suvar(3)7"
FT   REGION          488..490
FT                   /note="S-adenosyl-L-methionine binding"
FT                   /evidence="ECO:0000250"
FT   REGION          560..561
FT                   /note="S-adenosyl-L-methionine binding"
FT                   /evidence="ECO:0000250"
FT   METAL           412
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250"
FT   METAL           412
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250"
FT   METAL           414
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250"
FT   METAL           421
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250"
FT   METAL           421
FT                   /note="Zinc 3"
FT                   /evidence="ECO:0000250"
FT   METAL           427
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250"
FT   METAL           428
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250"
FT   METAL           428
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250"
FT   METAL           456
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250"
FT   METAL           456
FT                   /note="Zinc 3"
FT                   /evidence="ECO:0000250"
FT   METAL           460
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250"
FT   METAL           462
FT                   /note="Zinc 3"
FT                   /evidence="ECO:0000250"
FT   METAL           466
FT                   /note="Zinc 3"
FT                   /evidence="ECO:0000250"
FT   METAL           563
FT                   /note="Zinc 4"
FT                   /evidence="ECO:0000250"
FT   METAL           623
FT                   /note="Zinc 4"
FT                   /evidence="ECO:0000250"
FT   METAL           625
FT                   /note="Zinc 4"
FT                   /evidence="ECO:0000250"
FT   METAL           630
FT                   /note="Zinc 4"
FT                   /evidence="ECO:0000250"
FT   BINDING         531
FT                   /note="S-adenosyl-L-methionine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00190"
FT   CONFLICT        275
FT                   /note="T -> I (in Ref. 4; AAF55154)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        509
FT                   /note="G -> E (in Ref. 1; CAA56376)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        627
FT                   /note="R -> A (in Ref. 4; AAF55154)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   635 AA;  71904 MW;  4154A49F54B60E14 CRC64;
     MATAEAQIGV NRNLQKQDLS NLDVSKLTPL SPEVISRQAT INIGTIGHVA HGKSTVVKAI
     SGVQTVRFKN ELERNITIKL ERLSEKKIKN LLTSKQQRQQ YEIKQRSMLR HLAELRRHSR
     FRRLCTKPAS SSMPASTSSV DRRTTRRSTS QTSLSPSNSS GYGSVFGCEE HDVDKIPSLN
     GFAKLKRRRS SCVGAPTPNS KRSKNNMGVI AKRPPKGEYV VERIECVEMD QYQPVFFVKW
     LGYHDSENTW ESLANVADCA EMEKFVERHQ QLYETYIAKI TTELEKQLEA LPLMENITVA
     EVDAYEPLNL QIDLILLAQY RAAGSRSQRE PQKIGERALK SMQIKRAQFV RRKQLADLAL
     FEKRMNHVEK PSPPIRVENN IDLDTIDSNF MYIHDNIIGK DVPKPEAGIV GCKCTEDTEE
     CTASTKCCAR FAGELFAYER STRRLRLRPG SAIYECNSRC SCDSSCSNRL VQHGRQVPLV
     LFKTANGSGW GVRAATALRK GEFVCEYIGE IITSDEANER GKAYDDNGRT YLFDLDYNTA
     QDSEYTIDAA NYGNISHFIN HSCDPNLAVF PCWIEHLNVA LPHLVFFTLR PIKAGEELSF
     DYIRADNEDV PYENLSTAVR VECRCGRDNC RKVLF
//
